Loading...
Loading...
Market Overview The ABBV stock closed at 263.27 on September 29, 2026, reflecting a decline of 1.21% from the previous close of 266.50. Over the past 30 days, the stock has experienced a modest uptrend with a positive return of 1.67%, ranging between a low of 246.77 and a high of 269.39. Technical levels show the 20-day moving average at 260.97, the 50-day at 257.48, and the 200-day at 230.95, with the price trading above the short-term average. The 14-day RSI stands at 54.8, in neutral territory, indicating balanced momentum. Key support is at 246.77, while resistance is near 269.39. The Sigmanomics forecast model currently projects a bearish bias for the near term. AbbVie Inc. (ABBV) is a publicly traded stock covered by the Sigmanomics analytics platform. ABBV is listed on the BMV in Mexico. Over the same 30-day window, daily-return volatility was 1.19%, reflecting typical price variability for this stock. Across the past 52 weeks, the stock has traded between 190.75 and 269.39, with the current price near the high end of that range. Updated 9/29/26

Sam Bourgi is an analyst, writer and financial market commentator featured in and cited by U.S. Congress, Department of Justice, Chicago Board Options Exchange, Barron's and Forbes. He covers stocks, bonds, mutual funds, ETFs, forex, Bitcoin, cryptocurrency, real estate and macroeconomics. He has written over 25,000 articles and over 40 whitepapers and e-books.